What are the Challenges in Using Pro Apoptotic Agents?
One major challenge is the selectivity of these agents. They must selectively target malignant or damaged cells without harming normal, healthy cells. Another challenge is the risk of resistance, as cancer cells can develop mechanisms to evade apoptosis. Additionally, there can be unintended side effects due to broad systemic activation of apoptotic pathways.
